A brand new drug that might sluggish the development of Alzheimer’s disease has been accepted as protected to make use of – but it surely has additionally been deemed as too expensive to be prescribed on the NHS.
The Medicines and Healthcare merchandise Regulatory Company (MHRA) has on Thursday stated Lecanemab is protected and efficient, reports Sky News.
